产品介绍
| 产品名称 Anti-Neogenin抗体[EPR25220-56] (BSA and Azide free) 参阅全部 Neogenin 一抗 描述 兔单克隆抗体[EPR25220-56] to Neogenin - BSA and Azide free 宿主 Rabbit 经测试应用 适用于: WB, IP, ICC/IFmore details 不适用于: Flow Cyt or IHC-P 种属反应性 与反应: Human 不与反应: Mouse, Rat 免疫原 Recombinant fragment. This information is proprietary to Abcam and/or its suppliers. 阳性对照 WB: Whole cell lysates: A549 (human lung carcinoma epithelial cell) transfected with scrambled and targeted Neogenin siRNA, SW480 (human colorectal adenocarcinoma epithelial cell), Caco-2 (human colorectal adenocarcinoma epithelial cell), untreated A549, A549 treated with Protein Deglycosylation MIX II, His-tagged human Neogenin recombinant protein. ICC/IF: SW480 (human colorectal adenocarcinoma epithelial cell), A549 (human lung carcinoma epithelial cell). IP: A549. 常规说明 ab302543 is a carrier free version of ab302542. ab302542 does not react in: IHC-P with human, mouse, and rat species; flow cytometry with human and mouse species; WB, ICC and IP with mouse. This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com. Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with <1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold. This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free production For more information see here. Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents. |